Latest Breaking News On - Daniel kevin richards - Page 1 : comparemela.com
Utah pharmacy CEO sentenced for intending to sell mislabeled drug from China © Provided by KUTV Salt Lake City
A Utah pharmacy CEO will spend the next three years on probation after he pleaded guilty to receiving misbranded chloroquine from China with the intent to sell it in the United States.
Daniel Kevin Richards, 37, of Sandy, Utah, will also be required to pay $10,000, a judge ruled in federal court Monday, according to the Utah U.S. Attorney’s Office.
As part of his plea agreement, Richards, the CEO of Meds In Motion, admitted to importing and receiving over 50 kilograms of misbranded and mislabeled chloroquine from China in April of 2020 a month after the coronavirus pandemic began.
China
United-states
University-of-utah
Utah
Donald-trump
Daniel-kevin-richards
Utah-us-attorney-office
University-of-utah-health
Utah-department-of-health
Drug-administration
Kevin-richards
Meds-in-motion
Richards Pleads Guilty to Charge of Receipt of Misbranded Drugs Imported from China
Posted on
Richards Imported 50 kilograms of Mislabeled Chloroquine from China with the Intent to Sell the Drug in the United States
SALT LAKE CITY – Daniel Kevin Richards, 37, of Sandy, Utah, pleaded guilty to receiving misbranded chloroquine from China with the intent to sell the drug in the United States. In the plea agreement, Richards admitted that, in April of 2020, he imported and received over 50 kilograms of misbranded and mislabeled chloroquine from China. Richards admitted that the chloroquine was falsely mislabeled as “Boswellia Serrata Extract” and that the drug was not manufactured and prepared by an establishment registered as a drug manufacturer with the Food and Drug Administration. Additionally, the labeling on the drugs failed to bear adequate directions for use as required by federal law. At sentencing, Richards faces a maximum possible sentence of up to a year in prison a
China
United-states
Salt-lake-county
Utah
Johnw-huber
Daniel-kevin-richards
Charlesl-grinstead
Utah-us-attorney-office
Salt-lake-county-district-attorney-office
Drug-office-of-criminal-investigations
Drug-administration
United-states-attorney-john
Deseret News
Share this story
MedsInMotion.com
SALT LAKE CITY The owner of a Utah pharmacy who made a deal to sell the state thousands of doses of hydroxychloroquine as a controversial treatment for COVID-19 admitted in federal court Friday that drugs he bought from China were improperly branded.
Daniel Kevin Richards, the CEO of Draper-based Meds in Motion, pleaded guilty to one misdemeanor count of receipt of misbranded drugs in interstate commerce in U.S. District Court.
Richards received 50 kilograms of chloroquine and more than 500 kilograms of hydroxychloroquine around April 8, 2020, according to court documents. The product was falsely labeled as boswellia serrata extract, a resin taken from the bark of the boswellia tree grown in India, North Africa and the Middle East used to treat inflammation.
China
India
Utah
United-states
Greg-skordas
Charles-grinstead
Donald-trump
Daniel-kevin-richards
John-huber
Department-of-justice
Office-of-criminal-investigations
Drug-administration
vimarsana © 2020. All Rights Reserved.